AAV serotype influences gene transfer in corneal stroma in vivo

Experimental Eye Research

Volumn 91, Issue 3, 2010, Pages 440-448

  Sharma, Ajay ^a,b   Tovey, Jonathan C K ^a,b   Ghosh, Arkasubhra ^d   Mohan, Rajiv R ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b University of Missouri   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CD11B ANTIGEN; PARVOVIRUS VECTOR; DIFFERENTIATION ANTIGEN; MONOCYTE-MACROPHAGE DIFFERENTIATION ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; CORNEA; CORNEA CELL; CORNEA EPITHELIUM; CYTOCHEMISTRY; FEMALE; GENE EXPRESSION; GENETIC CODE; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATITIS; MOUSE; NICK END LABELING; NONHUMAN; PLASMID; PRIORITY JOURNAL; SEROTYPE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; ANIMAL; C57BL MOUSE; CLASSIFICATION; CORNEA STROMA; DEPENDOPARVOVIRUS; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; METABOLISM; PHYSIOLOGY; SEROTYPING;

ALKALINE PHOSPHATASE; ANIMALS; ANTIGENS, CD11B; ANTIGENS, DIFFERENTIATION; CORNEAL STROMA; DEPENDOVIRUS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC VECTORS; HUMANS; IN SITU NICK-END LABELING; MICE; MICE, INBRED C57BL; PLASMIDS; SEROTYPING; TRANSDUCTION, GENETIC;

EID: 77955846168     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2010.06.020     Document Type: Article

References (37)

1. Akache B., Grimm D., Pandey K., Yant S.R., Xu H., Kay M.A. The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9. J. Virol. 2006, 80:9831-9836.
2. Alexander J.J., Hauswirth W.W. Adeno-associated viral vectors and the retina. Adv. Exp. Med. Biol. 2008, 613:121-128.
3. Bainbridge J.W., Smith A.J., Barker S.S., Robbie S., Henderson R., Balaggan K., Viswanathan A., Holder G.E., Stockman A., Tyler N., Petersen-Jones S., Bhattacharya S.S., Thrasher A.J., Fitzke F.W., Carter B.J., Rubin G.S., Moore A.T., Ali R.R. Effect of gene therapy on visual function in Leber's congenital amaurosis. N. Engl. J. Med. 2008, 358:2231-2239.
4. Behrens A., Gordon E.M., Li L., Liu P.X., Chen Z., Peng H., La Bree L., Anderson W.F., Hall F.L., McDonnell P.J. Retroviral gene therapy vectors for prevention of excimer laser-induced corneal haze. Invest. Ophthalmol. Vis. Sci. 2002, 43:968-977.
5. Bennett J., Duan D., Engelhardt J.F., Maguire A.M. Real-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction. Invest. Ophthalmol. Vis. Sci. 1997, 38:2857-2863.
6. Bish L.T., Morine K., Sleeper M.M., Sanmiguel J., Wu D., Gao G., Wilson J.M., Sweeney L. AAV9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. Hum. Gene Ther. 2008, 19:1359-1368.
7. Broekman M.L., Comer L.A., Hyman B.T., Sena-Esteves M. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain. Neuroscience 2006, 138:501-510.
8. Calcedo R., Vandenberghe L.H., Gao G., Lin J., Wilson J.M. Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses. J. Infect. Dis. 2009, 199:381-390.
9. Cheng H.C., Yeh S.I., Tsao Y.P., Kuo P.C. Subconjunctival injection of recombinant AAV-angiostatin ameliorates alkali burn induced corneal angiogenesis. Mol. Vis. 2007, 13:2344-2352.
10. Denby L., Nicklin S.A., Baker A.H. Adeno-associated virus (AAV)-7 and -8 poorly transduce vascular endothelial cells and are sensitive to proteasomal degradation. Gene Ther. 2005, 12:1534-1538.
11. Gao G., Vandenberghe L.H., Wilson J.M. New recombinant serotypes of AAV vectors. Curr. Gene Ther. 2005, 5:285-297.
12. Gao G.P., Alvira M.R., Wang L., Calcedo R., Johnston J., Wilson J.M. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:11854-11859.
13. Gao G.P., Lu Y., Calcedo R., Grant R.L., Bell P., Wang L., Figueredo J., Lock M., Wilson J.M. Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates. Mol. Ther. 2006, 13:77-87.
14. Ghosh A., Yue Y., Duan D. Viral serotype and the transgene sequence influence overlapping adeno-associated viral (AAV) vector-mediated gene transfer in skeletal muscle. J. Gene Med. 2006, 8:298-305.
15. Howard D.B., Powers K., Wang Y., Harvey B.K. Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitro. Virology 2008, 372:24-34.
16. Klausner E.A., Peer D., Chapman R.L., Multack R.F., Andurkar S.V. Corneal gene therapy. J. Control. Release 2007, 124:107-133.
17. Lebherz C., Maguire A., Tang W., Bennett J., Wilson J.M. Novel AAV serotypes for improved ocular gene transfer. J. Gene Med. 2008, 10:375-382.
18. Limberis M.P., Wilson J.M. Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:12993-12998.
19. Maguire A.M., Simonelli F., Pierce E.A., Pugh E.N., Mingozzi F., Bennicelli J., Banfi S., Marshall K.A., Testa F., Surace E.M., Rossi S., Lyubarsky A., Arruda V.R., Konkle B., Stone E., Sun J., Jacobs J., Dell'Osso L., Hertle R., Ma J.X., Redmond T.M., Zhu X., Hauck B., Zelenaia O., Shindler K.S., Maguire M.G., Wright J.F., Volpe N.J., McDonnell J.W., Auricchio A., High K.A., Bennett J. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N. Engl. J. Med. 2008, 358:2240-2248.
20. Masur S.K., Cheung J.K., Antohi S. Identification of integrins in cultured corneal fibroblasts and in isolated keratocytes. Invest. Ophthalmol. Vis. Sci. 1993, 34:2690-2698.
21. Mohan R.R., Schultz G.S., Hong J.W., Mohan R.R., Wilson S.E. Gene transfer into rabbit keratocytes using AAV and lipid-mediated plasmid DNA vectors with a lamellar flap for stromal access. Exp. Eye Res. 2003, 76:373-383.
22. Mohan R.R., Schultz G.S., Sharma A., Sinha S., Netto M.V., Wilson S.E. Controlled and site-selective gene delivery into mouse keratocytes by adeno-associated viral, lentiviral and plasmid vectors. Invest. Ophthalmol. Vis. Sci. 2005, 46. E-2163.
23. Mohan R.R., Sharma A., Netto M.V., Sinha S., Wilson S.E. Gene therapy in the cornea. Prog. Retin. Eye Res. 2005, 24:537-559.
24. Negishi A., Chen J., McCarty D.M., Samulski R.J., Liu J., Superfine R. Analysis of the interaction between adeno-associated virus and heparan sulfate using atomic force microscopy. Glycobiology 2004, 14:969-977.
25. Pacak C.A., Mah C.S., Thattaliyath B.D., Conlon T.J., Lewis M.A., Cloutier D.E., Zolotukhin I., Tarantal A.F., Byrne B.J. Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo. Circ. Res. 2006, 99:e3-e9.
26. Parker D.G., Brereton H.M., Coster D.J., Williams K.A. The potential of viral vector-mediated gene transfer to prolong corneal allograft survival. Curr. Gene Ther. 2009, 9:33-44.
27. Parks W.P., Boucher D.W., Melnick J.L., Taber L.H., Yow M.D. Seroepidemiological and ecological studies of the adenovirus-associated satellite viruses. Infect. Immun. 1970, 2:716-722.
28. Saika S., Yamanaka O., Sumioka T., Miyamoto T., Miyazaki K., Okada Y., Kitano A., Shirai K., Tanaka S., Ikeda K. Fibrotic disorders in the eye: targets of gene therapy. Prog. Retin. Eye Res. 2008, 27:177-196.
29. Seiler M.P., Miller A.D., Zabner J., Halbert C.L. Adeno-associated virus types 5 and 6 use distinct receptors for cell entry. Hum. Gene Ther. 2006, 17:10-19.
30. Sharma A., Ghosh A., Hansen E.T., Newman J.M., Mohan R.R. Transduction efficiency of AAV 2/6, 2/8 and 2/9 vectors for delivering genes in human corneal fibroblasts. Brain Res. Bull. 2010, 81:273-278.
31. Stepp M.A. Corneal integrins and their functions. Exp. Eye Res. 2006, 83:3-15.
32. Summerford C., Samulski R.J. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 1998, 72:1438-1445.
33. Surace E.M., Auricchio A. Versatility of AAV vectors for retinal gene transfer. Vis. Res. 2008, 48:353-359.
34. Van Vliet K.M., Blouin V., Brument N., Agbandje-McKenna M., Snyder R.O. The role of the adeno-associated virus capsid in gene transfer. Methods Mol. Biol. 2008, 437:51-91.
35. Verma I.M., Weitzman M.D. Gene therapy: twenty-first century medicine. Annu. Rev. Biochem. 2005, 74:711-738.
36. Wang Z., Zhu T., Qiao C., Zhou L., Wang B., Zhang J., Chen C., Li J., Xiao X. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat. Biotechnol. 2005, 23:321-328.
37. Wu Z., Miller E., Agbandje-McKenna M., Samulski R.J. Alpha2,3 and alpha2, 6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6. J. Virol. 2006, 80:9093-9103.